Source: Zacks

Recursion: Recursion Pharmaceuticals (RXRX) Stock Moves -1.64%: What You Should Know

Recursion Pharmaceuticals (RXRX) reachead $5.41 at the closing of the latest trading day, reflecting a -1.64% change compared to its last close.

Read full article »
Annual Revenue
$25-100M
Employees
500-1.0K
Christopher C. Gibson's photo - Co-Founder & CEO of Recursion

Co-Founder & CEO

Christopher C. Gibson

CEO Approval Rating

81/100

Read more